
The geopolitical race between the US and China is accelerating investment in Artificial Intelligence, creating a major long-term opportunity for investors. Consider exposure to leading US AI companies like NVIDIA (NVDA), Google (GOOGL), and Microsoft (MSFT) that are positioned to benefit from policies designed to maintain a competitive edge. In China, Alibaba (BABA) is a key beneficiary of a government mandate requiring 95% of its institutions to use AI by 2030, though this investment carries significant geopolitical risk. Conversely, investors should be cautious with the pharmaceutical sector due to a growing bipartisan political risk of government intervention to lower drug prices. This potential policy shift could create a significant long-term headwind for the industry's profitability.

By All-In Podcast, LLC
Industry veterans, degenerate gamblers & besties Chamath Palihapitiya, Jason Calacanis, David Sacks & David Friedberg cover all things economic, tech, political, social & poker.